| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Culverwell Anthony James is a Director at Quoin Pharmaceuticals, Ltd.. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $461K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 23, 2024 | QNRX Quoin Pharmaceuticals, Ltd. | Director | Buy | 100,000 | $0.45 | $45,000.00 | +31,546% | -43.3% | -26.9% |